Submitted:
09 June 2026
Posted:
10 June 2026
You are already at the latest version
Abstract

Keywords:
1. Introduction
2. Adaptation Operates Across Distinct Timescales
3. The Four Adaptive Layers and Their Evidence
3.1. The Fast Adaptive Layer (M): Redox and Radical Chemistry
3.2. The Collective Organizational Layer (C): Intercellular Communication and Tissue Structure
3.3. The Persistent Adaptive Layer (B): Epigenetic Memory
3.4. The Evolutionary Layer (E): Clonal Selection
4. Coupled Dynamics: The Structural Core of the Framework
4.1. A Minimal Representation
4.2. Oxygen as a Vertical Thread (Bottom-Up and Top-Down Through All Bands)
4.3. The C→B Coupling: Transient Signal to Durable State
4.4. The B↔E Coupling: Induced State and Selection
4.5. The Remaining Couplings
4.6. Treatment as Perturbation of a Coupled System
5. The Radiobiological Anomalies as Band-Specific Perturbations
5.1. FLASH as a Fast-State Perturbation
5.2. SFRT As a Collective-Organizational Perturbation
5.3. SBRT As a High-Magnitude Perturbation
5.4. Resistance as a Persistent–Evolutionary Perturbation
6. Existing Models as Limiting Cases
7. Methods: The Coupled System as an Explicit Dynamical Model
7.1. The Shared Kill Kernel
7.2. Spatial Structure: The Collective and Persistent Layers as Fields
7.3. Recovering the Conventional Models
7.4. The Evolutionary Layer and the Closed Loop
7.5. Cross-Modality Interaction: An Elementary Identity With Non-Elementary Consequences
8. Results
8.1. The Persistent State is Written in the Unirradiated Valleys
8.2. The Evolutionary Layer Reproduces The Adaptive-Therapy Trade-Off
8.3. Closing the Loop Produces History-Dependence at Fixed Dose
8.4. The Persistent Write is a Bistable Switch with Threshold and Hysteresis
8.5. Spatially Fractionated Geometry Has an Optimum for Memory Writing
8.6. FLASH and SFRT Interact Non-Additively
8.7. Consolidated View and What the Results Imply
9. Predictions
9.1. Predictions Requiring Couplings the Model Contains but Cannot Yet Constrain
9.2. Predictions Requiring Structures Not yet in the Model
9.3. Predictions Requiring New External Variables
10. Discussion
10.1. What the Framework Adds Beyond Conventional Radiobiology
10.2. Relation to Existing Multi-Scale Mechanistic Models
10.3. Implications for Radiotherapy Planning and Delivery
10.4. Limitations

| Symbol | Meaning |
| D, Ḋ | cumulative dose; instantaneous dose rate |
| SF, Σ | surviving fraction; log-kill, Σ ≡ −ln SF |
| X | full multi-scale state vector, X = (M, C, B, E) and, in the Methods, its resolved variables |
| M, C, B, E | the four layers: fast redox (M), collective (C), persistent epigenetic (B), evolutionary (E) |
| U(t) | treatment input (dose, dose rate, temporal and spatial structure) |
| fM, fC, fB, fE | layer evolution functions |
| α0, β0 | intrinsic (baseline) linear and quadratic radiosensitivity |
| α(X), β(X) | state-dependent radiosensitivity coefficients |
| Φ(X) | master modulation function, Φ = ω(p)(1 − κB B) |
| p, ω(p) | oxygen tension; oxygen sensitivity factor |
| r(p) | redox excursion driving the persistent-state write |
| s(x, D) | bystander signal field (collective layer, C) |
| σ(x) | delivered spatial dose pattern (high at peaks, zero in valleys) |
| Ds, μs, gs | signal diffusion coefficient; decay rate; generation rate |
| V | vascular-damage variable (collective layer, C) |
| B(x, D) | persistent epigenetic state field (B layer) |
| kw, kr | write rate; reversal (forgetting) rate of B |
| kfb, Kh, h | AP-1 self-activation strength; half-saturation constant; Hill exponent |
| Ε | strength of the redox (M→B) write contribution |
| Ns, Nr | sensitive and resistant cell populations (evolutionary layer, E) |
| E | resistant fraction, E = Nr/(Ns + Nr) |
| Φs, Φr | modulation factors for the sensitive and resistant compartments |
| rs, rr | proliferation rates of sensitive and resistant cells |
| C | fitness cost of resistance, rr = (1 − c) rs |
| m(B) | maturation flux from induced reservoir to fixed resistance, m(B) = sE B |
| K(E) | carrying capacity, reduced by the resistant fraction, K0(1 − cK E) |
| χB, χE | strengths of the B→C and E→C downward (top-down) couplings |
| cK | strength of the E→carrying-capacity constraint |
| κB | suppression of radiosensitivity by the persistent state |
| δω, δB | departures of ω and B from baseline (interaction analysis) |
| Layer | Timescale | Representative biology | Evidence level | Key examples |
| M -fast adaptive | Milliseconds–seconds | Radiolytic oxygen depletion and recovery, radical recombination, fast damage fixation | Established biology (as dynamic oxygen/radical chemistry); the novel-layer status beyond known chemistry is unestablished | Pratx & Kapp (2019) ROD model; Labarbe et al. (2020) radical recombination; UNIVERSE model (Liew et al. 2021, 2022) |
| C — collective organizational | Seconds–days | Bystander signaling, intercellular communication, vascular/perfusion structure, bioelectric tissue organization | Established biology (bystander effects, non-cell-autonomous behavior); collective-state framing is strongly supported synthesis; intracellular epigenetic-memory through AP-1 (proposed, not established) | McMahon et al. (2013) kinetic signaling model; Marusyk et al. (2014) non-cell-autonomous growth; SFRT valley response (Casteloes et al. 2025); Levin (2021) bioelectric organization; Vaitheeswaran (2026b) |
| B — persistent adaptive (epigenetic memory) | Days–weeks | Reversible non-genetic drug-tolerant states, transcriptional/chromatin conditioning, AP-1 cis-memory | Strongly supported synthesis; the C→B write mechanism rests on demonstrated molecular biology (AP-1) | Sharma et al. (2010) chromatin-mediated tolerance; Li et al. (2026) AP-1 memory; Lopez-Gonzalez et al. (2026) DTP scoping review; Eckert et al. (2024), Doan et al. (2026), Pigozzi et al. (2025) for substrate-general memory |
| E — evolutionary | Weeks–months | Clonal selection, competition, ecological/fitness dynamics under treatment pressure | Established biology | Greaves & Maley (2012) clonal evolution; Gatenby & Brown (2020) and Zhang et al. (2017) adaptive therapy; Valcz et al. (2025) induced-and-inherited framing |
References
- Asur, R., Butterworth, K. T., Penagaricano, J. A., Prise, K. M., & Griffin, R. J. (2015). High dose bystander effects in spatially fractionated radiation therapy. Cancer Letters, 356(1), 52–57. [CrossRef]
- Boscolo, D., Scifoni, E., Carlino, A., et al. (2024). The oxygen puzzle in FLASH radiotherapy: A comprehensive review and experimental outlook. Clinical and Translational Radiation Oncology, 49, 100863.
- Brown, J. M., Carlson, D. J., & Brenner, D. J. (2014). The tumor radiobiology of SRS and SBRT: Are more than the 5 Rs involved? International Journal of Radiation Oncology, Biology, Physics, 88(2), 254–262. [CrossRef]
- Cao, X., Zhang, R., Esipova, T. V., et al. (2021). Quantification of oxygen depletion during FLASH irradiation in vitro and in vivo. International Journal of Radiation Oncology, Biology, Physics, 111(1), 240–248. [CrossRef]
- Casteloes, N., House, C. D., & Tambasco, M. (2025). A 3D co-culture scaffold approach to assess spatially fractionated radiotherapy bystander and abscopal immune effects on clonogenic survival. International Journal of Molecular Sciences, 26(9), 4436. [CrossRef]
- Chis, O.-T., Banga, J. R., & Balsa-Canto, E. (2011). Structural identifiability of systems biology models: A critical comparison of methods. PLoS ONE, 6(11), e27755. [CrossRef]
- Doan, V., et al. (2026). Associative learning in the single-celled organism Stentor coeruleus. bioRxiv, 2026.02.25.708045.
- Eckert, L., et al. (2024). Habituation as an emergent property of biochemical reaction networks. Current Biology, 34(24), 5646–5658. [CrossRef]
- Ellis, G. F. R. (2012). Top-down causation and emergence: some comments on mechanisms. Interface Focus 2(1), 126–140. [CrossRef]
- Favaudon, V., Caplier, L., Monceau, V., et al. (2014). Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice. Science Translational Medicine, 6(245), 245ra93. [CrossRef]
- Fowler, J. F. (1989). The linear-quadratic formula and progress in fractionated radiotherapy. British Journal of Radiology, 62(740), 679–694. [CrossRef]
- Gatenby, R. A., & Brown, J. S. (2020). Integrating evolutionary dynamics into cancer therapy. Nature Reviews Clinical Oncology, 17(11), 675–686. [CrossRef]
- Gelman, A., Carlin, J. B., Stern, H. S., Dunson, D. B., Vehtari, A., & Rubin, D. B. (2013). Bayesian Data Analysis (3rd ed.). Chapman and Hall/CRC.
- Greaves, M., & Maley, C. C. (2012). Clonal evolution in cancer. Nature, 481(7381), 306–313. [CrossRef]
- Griffin, R. J., Ahmed, M. M., Amendola, B., et al. (2020). Understanding high-dose, ultra-high dose-rate, and spatially fractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 107(4), 766–778. [CrossRef]
- Gutenkunst, R. N., Waterfall, J. J., Casey, F. P., Brown, K. S., Myers, C. R., & Sethna, J. P. (2007). Universally sloppy parameter sensitivities in systems biology models. PLoS Computational Biology, 3(10), e189. [CrossRef]
- Jin, J., et al. (2025). Re-examining the oxygen depletion hypothesis in FLASH radiotherapy. Radiotherapy and Oncology (in press).
- Kirkpatrick, J. P., Meyer, J. J., & Marks, L. B. (2008). The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Seminars in Radiation Oncology, 18(4), 240–243. [CrossRef]
- Kutcher, G. J., Burman, C., Brewster, L., Goitein, M., & Mohan, R. (1991). Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. International Journal of Radiation Oncology, Biology, Physics, 21(1), 137–146. [CrossRef]
- Labarbe, R., Hotoiu, L., Barbier, J., & Favaudon, V. (2020). A physicochemical model of reaction kinetics supports peroxyl radical recombination as the main determinant of the FLASH effect. Radiotherapy and Oncology, 153, 303–310. [CrossRef]
- Levin, M. (2021). Bioelectric signaling: Reprogrammable circuits underlying embryogenesis, regeneration, and cancer. Cell, 184(8), 1971–1989. [CrossRef]
- Li, B., et al. (2025). Drug-tolerant persister cell states in cancer (review). Cell Reports Medicine (in press).
- Li, X., & Raj, A., et al. (2026). AP-1 mediates the formation of cellular memory during the acquisition of therapy resistance. Nature Communications, 17, 4265. [CrossRef]
- Liew, H., Mein, S., Dokic, I., Haberer, T., Debus, J., Abdollahi, A., & Mairani, A. (2021). Deciphering time-dependent DNA damage complexity, repair, and oxygen tension: A mechanistic model for FLASH-dose-rate radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 110(2), 574–586. [CrossRef]
- Liew, H., Mein, S., Tessonnier, T., Abdollahi, A., Debus, J., Dokic, I., & Mairani, A. (2022). The impact of sub-millisecond damage fixation kinetics on the in vitro sparing effect at ultra-high dose rate in UNIVERSE. International Journal of Molecular Sciences, 23(6), 2954. [CrossRef]
- Lopez-Gonzalez, J. S., Perez-Medina, M., Galicia-Velasco, M., & Aguilar-Cazares, D. (2026). Drug-tolerant persister cells in cancer: a scoping review of definitions, models, and molecular mechanisms. Frontiers in Oncology, 16, 1771061. [CrossRef]
- Lyman, J. T. (1985). Complication probability as assessed from dose-volume histograms. Radiation Research Supplement, 8, S13–S19.
- Marusyk, A., Tabassum, D. P., Altrock, P. M., Almendro, V., Michor, F., & Polyak, K. (2014). Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity. Nature, 514(7520), 54–58. [CrossRef]
- McMahon, S. J., Butterworth, K. T., McGarry, C. K., et al. (2013). A kinetic-based model of radiation-induced intercellular signalling. PLOS ONE, 8(1), e54526. [CrossRef]
- McMahon, S. J., Schuemann, J., Paganetti, H., & Prise, K. M. (2016). Mechanistic modelling of DNA repair and cellular survival following radiation-induced DNA damage. Scientific Reports, 6, 33290. [CrossRef]
- McMahon, S. J., & Prise, K. M. (2021). Mechanistic modelling of radiation responses. Cancers, 13(9), 2154. [CrossRef]
- Noble, D. (2012). A theory of biological relativity: no privileged level of causation. Interface Focus 2(1), 55–64. [CrossRef]
- Pigozzi, F., et al. (2025). Associative conditioning in gene regulatory networks increases integrated causal emergence. Communications Biology, 8, 1027. [CrossRef]
- Pisco, A. O., & Huang, S. (2015). Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse. British Journal of Cancer, 112(11), 1725–1732. [CrossRef]
- Powathil, G. G., Gordon, K. E., Hill, L. A., & Chaplain, M. A. J. (2012). Modelling the effects of cell-cycle heterogeneity on the response of a solid tumour to chemotherapy: Biological insights from a hybrid multiscale cellular automaton model. Journal of Theoretical Biology, 308, 1–19. [CrossRef]
- Powathil, G. G., Munro, A. J., Chaplain, M. A. J., & Swat, M. (2016). Bystander effects and their implications for clinical radiation therapy: Insights from multiscale in silico experiments. Journal of Theoretical Biology, 401, 1–14. [CrossRef]
- Pratx, G., & Kapp, D. S. (2019). A computational model of radiolytic oxygen depletion during FLASH irradiation and its effect on the oxygen enhancement ratio. Physics in Medicine & Biology, 64(18), 185005. [CrossRef]
- Raue, A., Kreutz, C., Maiwald, T., Bachmann, J., Schilling, M., Klingmüller, U., & Timmer, J. (2009). Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood. Bioinformatics, 25(15), 1923–1929. [CrossRef]
- Ribba, B., Colin, T., & Schnell, S. (2006). A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies. Theoretical Biology and Medical Modelling, 3, 7. [CrossRef]
- Shaffer, S. M., Dunagin, M. C., Torborg, S. R., et al. (2017). Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature, 546(7658), 431–435. [CrossRef]
- Sharma, S. V., Lee, D. Y., Li, B., et al. (2010). A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell, 141(1), 69–80. [CrossRef]
- Sheth, M., & Esfandiari, L. (2022). Bioelectric dysregulation in cancer initiation, promotion, and progression. Frontiers in Oncology, 12, 846917. [CrossRef]
- Song, C. W., Glatstein, E., Marks, L. B., et al. (2021). Biological principles of stereotactic body radiation therapy (SBRT) and stereotactic radiation surgery (SRS): Indirect cell death. International Journal of Radiation Oncology, Biology, Physics, 110(1), 21–34. [CrossRef]
- Vaitheeswaran, R. (2026a). The Ghost in the Cancer: Towards a New Science of Radiation Oncology. Notion Press. ISBN 979-8903629169.
- Vaitheeswaran, R. (2026b). Extending the kinetic-bystander model for spatially fractionated radiotherapy with intracellular epigenetic memory. Preprints. [CrossRef]
- Vaitheeswaran, R. (2026c). On the observability and structural identifiability of radiobiological models and the case for latent-state adaptive control. Preprints. [CrossRef]
- Valcz, G., Gatenby, R. A., Újvári, B., Buzás, E. I., & Molnár, B. (2025). Adaptive cancer therapy: can non-genetic factors become its Achilles heel? Oncogene, 44(42), 3999–4005. [CrossRef]
- Vozenin, M.-C., De Fornel, P., Petersson, K., et al. (2019). The advantage of FLASH radiotherapy confirmed in mini-pig and cat-cancer patients. Clinical Cancer Research, 25(1), 35–42. [CrossRef]
- Wang, Z., Wang, M., Dong, B., Wang, Y., Ding, Z., & Shen, S. (2025). Drug-tolerant persister cells in cancer: Bridging the gaps between bench and bedside. Nature Communications, 16, 10048. [CrossRef]
- Wang, S., Lei, J., Zou, X., & Jin, S. (2025). Integrating multiscale mathematical modeling and multidimensional data reveals the effects of epigenetic instability on acquired drug resistance in cancer. PLOS Computational Biology, 21(2), e1012815. [CrossRef]
- Zhang, J., Cunningham, J. J., Brown, J. S., & Gatenby, R. A. (2017). Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer. Nature Communications, 8, 1816. [CrossRef]






| # | Result | Mechanism / equation exercised | Qualitative signature | Conventional expectation it violates |
| 8.1 | Valley memory writing | Spatial reaction–diffusion of s; local B write | Durable marks in unirradiated valleys; B broader than dose | Durable effect tracks local dose |
| 8.2 | Adaptive-therapy trade-off | Two-compartment E layer; cost + competition | Continuous → all-resistant; adaptive → low resistance | Maximal dose is always optimal |
| 8.3 | Order-dependence at fixed dose | Closed C→B→E loop; stochastic maturation | Different resistant fraction, same total dose | BED / LQ are order-independent |
| 8.4 | Bistable threshold + hysteresis | AP-1 autoregulatory write | Abrupt switch; escalation ≠ de-escalation path | Graded, history-independent response |
| 8.5 | SFRT geometric optimum | Spatial signal field + threshold write | Memory-optimal geometry ≠ dose-optimal | Optimize peak/valley dose or PVDR |
| 8.6 | FLASH × SFRT non-additivity | Bilinear Φ; interaction term −κB·δω·δB | Combined ≠ sum; selective by shared variable | Modality effects superpose additively |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).